IFP Advisors, Inc - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2023$17
+13.3%
14
+100.0%
0.00%
Q1 2023$15
+1400.0%
70.0%0.00%
Q4 2022$1
-99.9%
70.0%0.00%
Q3 2022$1,0000.0%70.0%0.00%
Q2 2022$1,0000.0%70.0%0.00%
Q1 2022$1,00070.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,100,419$650,4580.10%
Virtu Financial LLC 58,883$350.00%
Simplicity Solutions, LLC 36,670$21,6760.00%
Renaissance Technologies 1,222,424$7230.00%
JPMORGAN CHASE & CO 293,036$173,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,359$220.00%
Gradient Investments LLC 63$370.00%
VANGUARD GROUP INC 2,427,778$1,435,0600.00%
Advisory Services Network, LLC 1$10.00%
Focused Wealth Management, Inc 222$1310.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders